Question 1

What health problems are Egyptian Mau prone to?

Accepted Answer

According to allpets.ai data, Egyptian Mau has 5 known health predispositions including Urolithiasis, Pyruvate Kinase Deficiency (PK-Def), Leukodystrophy. 4 of these are hereditary conditions. Regular veterinary screening and genetic testing are recommended for early detection.

Question 2

What is the average lifespan of a Egyptian Mau?

Accepted Answer

According to allpets.ai data, Egyptian Mau typically lives 9–20 years. Factors affecting longevity include genetics, diet, exercise, preventive care, and management of breed-specific health conditions.

Question 3

Is Egyptian Mau prone to obesity?

Accepted Answer

According to allpets.ai data, Egyptian Mau has medium obesity risk. Ideal body condition score: 5. Regular weight monitoring and portion control are recommended.

Question 4

What genetic tests should Egyptian Mau have?

Accepted Answer

According to allpets.ai data, CHIC required tests for Egyptian Mau: Pyruvate Kinase Deficiency (PK-Def), Hypertrophic Cardiomyopathy (HCM), Leukodystrophy.

Question 5

What preventive care does a Egyptian Mau need?

Accepted Answer

Essential preventive care for Egyptian Mau includes: annual wellness exams with breed-specific screenings, vaccinations, dental care, parasite prevention, and monitoring for the 5 known predisposed conditions. Early detection through regular check-ups significantly improves outcomes.

Lifespan	9–20 years
Weight Range	2.7–6.4 kg
Height Range	20–35 cm

Condition	Category	Risk Level	Hereditary	Screening
Urolithiasis	N/A	Moderate	Yes	Annual exam
Pyruvate Kinase Deficiency (PK-Def)	N/A	Moderate	Yes	Annual exam
Leukodystrophy	N/A	Moderate	Yes	Annual exam
Hypertrophic Cardiomyopathy (HCM)	N/A	Moderate	Yes	Annual exam
Umbilical Hernias	N/A	Moderate	No	Annual exam

Egyptian Mau Health Guide

Vital Statistics

Disease Predispositions (5)

Obesity & Weight Management

Genetic Screening

Related Resources

CHIC Required Tests	Pyruvate Kinase Deficiency (PK-Def), Hypertrophic Cardiomyopathy (HCM), Leukodystrophy
Dystocia Risk	medium